Recent Quotes View Full List My Watchlist Create Watchlist Indicators DJI Nasdaq Composite SPX Gold Crude Oil EL&P Market Index Markets Stocks ETFs Tools Overview News Currencies International Treasuries Travere Therapeutics Inc (NQ: TVTX ) 12.24 -0.60 (-4.67%) Streaming Delayed Price Updated: 4:00 PM EDT, Sep 11, 2024 Add to My Watchlist Quote Overview Detailed Quote Charting Historical Prices News All News News Headlines Press Releases Research Quarterly Reports Insider Filings Other Filings Headline News about Travere Therapeutics Inc < Previous 1 2 3 4 5 6 7 Next > 12 Health Care Stocks Moving In Wednesday's Pre-Market Session May 26, 2021 Gainers Pieris Pharmaceuticals (NASDAQ:PIRS) stock moved upwards by 20.74% to $4.54 during Wednesday's pre-market session. The market value of their outstanding shares... Via Benzinga The Daily Biotech Pulse: Nabriva Jumps On Data, Larimar Wilts After Study Put On Hold, Travere To Delay Regulatory Filing May 26, 2021 Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs May 25) ESSA Pharma Inc. (NASDAQ:... Via Benzinga 22 Stocks Moving in Wednesday's Pre-Market Session May 26, 2021 Gainers Nabriva Therapeutics plc (NASDAQ: NBRV) rose 48.8% to $2.20 in pre-market trading. Sinovant Sciences and Nabriva Therapeutics disclosed topline results from Phase 3 trial... Via Benzinga Earnings Scheduled For May 6, 2021 May 06, 2021 Companies Reporting Before The Bell • ViacomCBS (NASDAQ:VIAC) is projected to report quarterly earnings at $1.22 per share on revenue of $7.30 billion. • Cohen... Via Benzinga Retrophin Earnings Preview May 05, 2021 On Thursday, May 06, Retrophin (NASDAQ:TVTX) will release its latest earnings report. Check out Benzinga's preview to understand the implications. What Are Earnings, Net Income,... Via Benzinga Travere Therapeutics' Sparsentan Program Submission Pushed to 2022; FDA Requires More Data May 26, 2021 Following the pre-NDA meeting, the FDA has asked Travere Therapeutics Inc (NASDAQ: TVTX) to submit additional data for the sparsentan program in focal... Via Benzinga Exposures Product Safety 12 Health Care Stocks Moving In Tuesday's After-Market Session May 25, 2021 Gainers Pieris Pharmaceuticals (NASDAQ:PIRS Via Benzinga Stocks That Hit 52-Week Lows On Friday May 14, 2021 Before 10 a.m. ET on Friday, 24 stocks hit new 52-week lows. Noteworthy Mentions: The largest company in terms of market cap to set a new 52-week low was Canadian... Via Benzinga 12 Health Care Stocks Moving In Friday's Intraday Session May 07, 2021 Gainers Yield10 Bioscience (NASDAQ:YTEN) stock increased by 20.74% to $10.36 during Friday's regular session. As of 12:30 EST, Yield10 Bioscience's stock is... Via Benzinga Week Ahead In Biotech (May 2-8): ChemoCentryx Adcom, Ophthalmology Conference Presentations, Earnings Deluge May 01, 2021 Biopharma stocks experienced volatility in the week ended April 30, as stocks reacted to earnings, data readouts and a handful of FDA decisions. Earnings prints from big name... Via Benzinga Exposures Product Safety Stocks That Hit 52-Week Lows On Tuesday May 11, 2021 Before 10 a.m. ET Tuesday, 173 stocks hit new 52-week lows. Intriguing Points: The largest company by market cap to set a new 52-week low was Snowflake (NYSE:SNOW... Via Benzinga Stocks That Hit 52-Week Lows On Monday May 10, 2021 Monday morning saw 78 companies set new 52-week lows. Intriguing Points: The largest company by market cap to set a new 52-week low was Rocket Companies (NYSE:RKT).... Via Benzinga Stocks That Hit 52-Week Lows On Friday May 07, 2021 Friday's morning session saw 17 companies set new 52-week lows. Key Facts: Beyond Meat (NASDAQ:BYND) was the largest firm on a market cap basis to set a new 52-... Via Benzinga 70 Biggest Movers From Friday May 10, 2021 Gainers InnSuites Hospitality Trust (NYSE: IHT) shares gained 43.4% to close at $3.50 on Friday. Velocity Financial, Inc. (NYSE: VEL) rose 36.6% to close at $12.50 following Q1... Via Benzinga The Daily Biotech Pulse: Merck's Keytruda Snags Another FDA Approval, Moderna Slips On Revenue Miss, Chemocentryx Adcom May 06, 2021 Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs May 5) AbbVie Inc. (NYSE: ABBV)... Via Benzinga Exposures Product Safety < Previous 1 2 3 4 5 6 7 Next > Data & News supplied by www.cloudquote.io Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions.